APO RESEARCH · REPORT
Self Injection Device
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
Product & engineering
Understand the product.
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Selected research
Industry Research
Self Injection Device Industry Research Report 2026
Market perspective
The injectors were initially designed to overcome the hesitation associated with self-administration of the needle-based drug delivery device.
An auto-injector is a medical device designed to deliver a dose of a particular drug.
Market competition is not intense. Novo Nordisk, Mylan, Pfizer, Sanofi, BD, Eli Lilly and Gerresheimer, etc. are the leaders of the industry, with about 60% market shares.
Read the full market overview
Europe is the largest consumption place, with a consumption market share nearly 42%. Following Europe, North America is the second largest consumption place with the consumption market share of 31%.
Report Scope
This report quantifies the global Self Injection Device market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Self Injection Device Market by Company
Novo Nordisk
Mylan
Pfizer
Sanofi
BD
Eli Lilly
Gerresheimer
Dongbao
Ypsomed
Owen Mumford
Antares Pharma
Haselmeier
Self Injection Device Segment by Type
Reusable Self Injection Device
Disposable Self Injection Device
Self Injection Device Segment by Application
Insulin Injection
Epinephrine Injection
Others
Self Injection Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self Injection Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Self Injection Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self Injection Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Self Injection Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Self Injection Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Self Injection Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reusable Self Injection Device
- Disposable Self Injection Device
Applications
- Insulin Injection
- Epinephrine Injection
- Others
Companies covered
- Novo Nordisk
- Mylan
- Pfizer
- Sanofi
- BD
- Eli Lilly
- Gerresheimer
- Dongbao
- Ypsomed
- Owen Mumford
- Antares Pharma
- Haselmeier
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Self Injection Device Market Size (2021-2032)
- 2.2.2 Global Self Injection Device Sales (2021-2032)
- 2.2.3 Global Self Injection Device Market Average Price (2021-2032)
- 2.3 Self Injection Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Reusable Self Injection Device
- 2.3.3 Disposable Self Injection Device
- 2.4 Self Injection Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Insulin Injection
- 2.4.3 Epinephrine Injection
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Self Injection Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Self Injection Device Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Self Injection Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Self Injection Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Self Injection Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Self Injection Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Self Injection Device, Product Type & Application
- 3.8 Global Manufacturers of Self Injection Device, Established Date
- 3.9 Global Self Injection Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Self Injection Device Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Self Injection Device Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Self Injection Device Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Self Injection Device Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 BD
- 4.5.1 BD Company Information
- 4.5.2 BD Business Overview
- 4.5.3 BD Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BD Self Injection Device Product Portfolio
- 4.5.5 BD Recent Developments
- 4.6 Eli Lilly
- 4.6.1 Eli Lilly Company Information
- 4.6.2 Eli Lilly Business Overview
- 4.6.3 Eli Lilly Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Eli Lilly Self Injection Device Product Portfolio
- 4.6.5 Eli Lilly Recent Developments
- 4.7 Gerresheimer
- 4.7.1 Gerresheimer Company Information
- 4.7.2 Gerresheimer Business Overview
- 4.7.3 Gerresheimer Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Gerresheimer Self Injection Device Product Portfolio
- 4.7.5 Gerresheimer Recent Developments
- 4.8 Dongbao
- 4.8.1 Dongbao Company Information
- 4.8.2 Dongbao Business Overview
- 4.8.3 Dongbao Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dongbao Self Injection Device Product Portfolio
- 4.8.5 Dongbao Recent Developments
- 4.9 Ypsomed
- 4.9.1 Ypsomed Company Information
- 4.9.2 Ypsomed Business Overview
- 4.9.3 Ypsomed Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Ypsomed Self Injection Device Product Portfolio
- 4.9.5 Ypsomed Recent Developments
- 4.10 Owen Mumford
- 4.10.1 Owen Mumford Company Information
- 4.10.2 Owen Mumford Business Overview
- 4.10.3 Owen Mumford Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Owen Mumford Self Injection Device Product Portfolio
- 4.10.5 Owen Mumford Recent Developments
- 4.11 Antares Pharma
- 4.11.1 Antares Pharma Company Information
- 4.11.2 Antares Pharma Business Overview
- 4.11.3 Antares Pharma Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Antares Pharma Self Injection Device Product Portfolio
- 4.11.5 Antares Pharma Recent Developments
- 4.12 Haselmeier
- 4.12.1 Haselmeier Company Information
- 4.12.2 Haselmeier Business Overview
- 4.12.3 Haselmeier Self Injection Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Haselmeier Self Injection Device Product Portfolio
- 4.12.5 Haselmeier Recent Developments
5 Global Self Injection Device Market Scenario by Region
- 5.1 Global Self Injection Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Self Injection Device Sales by Region: 2021-2032
- 5.2.1 Global Self Injection Device Sales by Region: 2021-2026
- 5.2.2 Global Self Injection Device Sales by Region: 2027-2032
- 5.3 Global Self Injection Device Revenue by Region: 2021-2032
- 5.3.1 Global Self Injection Device Revenue by Region: 2021-2026
- 5.3.2 Global Self Injection Device Revenue by Region: 2027-2032
- 5.4 North America Self Injection Device Market Facts & Figures by Country
- 5.4.1 North America Self Injection Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Self Injection Device Sales by Country (2021-2032)
- 5.4.3 North America Self Injection Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Self Injection Device Market Facts & Figures by Country
- 5.5.1 Europe Self Injection Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Self Injection Device Sales by Country (2021-2032)
- 5.5.3 Europe Self Injection Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Self Injection Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Self Injection Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Self Injection Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Self Injection Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Self Injection Device Market Facts & Figures by Country
- 5.7.1 South America Self Injection Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Self Injection Device Sales by Country (2021-2032)
- 5.7.3 South America Self Injection Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Self Injection Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Self Injection Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Self Injection Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Self Injection Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Self Injection Device Sales by Type (2021-2032)
- 6.1.1 Global Self Injection Device Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Self Injection Device Sales Market Share by Type (2021-2032)
- 6.2 Global Self Injection Device Revenue by Type (2021-2032)
- 6.2.1 Global Self Injection Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Self Injection Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Self Injection Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Self Injection Device Sales by Application (2021-2032)
- 7.1.1 Global Self Injection Device Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Self Injection Device Sales Market Share by Application (2021-2032)
- 7.2 Global Self Injection Device Revenue by Application (2021-2032)
- 7.2.1 Global Self Injection Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Self Injection Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Self Injection Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Self Injection Device Value Chain Analysis
- 8.1.1 Self Injection Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Self Injection Device Production Mode & Process
- 8.2 Self Injection Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Self Injection Device Distributors
- 8.2.3 Self Injection Device Customers
9 Global Self Injection Device Analyzing Market Dynamics
- 9.1 Self Injection Device Industry Trends
- 9.2 Self Injection Device Industry Drivers
- 9.3 Self Injection Device Industry Opportunities and Challenges
- 9.4 Self Injection Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst